One and done: Reasons principal investigators conduct only one FDA-regulated drug trial

by Amy Corneli, PhD, MPH, Christine Pierre, RN, Terri Hinkley, RN, BScN, MBA, CCRC, Li Lin, MS, Christopher B. Fordyce, MD, MSc, Gerrit Hamre, MA, Matthew T. Roe, MD, MHS
Published 2017-06-01

Impact of Patient- and System-Level Delays on Reperfusion Among Patients With ST-Elevation Myocardial Infarction

by Joshua B. Wenner, MD, Graham C. Wong, MD, MPH, John A. Cairns, MD, Michele Perry-Arnesen, BScN, MHA, Wendy Tocher, RN, Martha Mackay, PhD, RN, Joel Singer, PhD, Terry Lee, PhD, Christopher B. Fordyce, MD, MHS, MSc
Published 2020-05-01

Management of Acute Coronary Syndromes Beyond the First Year: A Canadian Clinical Practice Survey

by Khai-Tuan A. Bui, Alexis Matteau, MD, SM, Basem Elbarouni, MD, Kevin R. Bainey, MD, Christopher B. Fordyce, MD, Akshay Bagai, MD, Barry Rose, MD, Sohrab Lutchmedial, MD, Benjamin Leis, MD, Andrea Lavoie, MD, Jafna Cox, MD, Samer Mansour, MD, Brian J. Potter, MDCM, SM
Published 2020-11-01